Automated Nuclear Pleomorphism Assessment via Shape Factor Analysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The pathological analysis of tissue samples for cancer diagnosis is a time-consuming and subjective process, leading to inconsistencies in observations among different observers and even the same observer over time, particularly in assessing nuclear pleomorphism in cancers like breast cancer.
Innovation Solution
An objective method for histological assessment of nuclear pleomorphism is developed, which involves identifying image regions corresponding to cell nuclei in histological image data, applying thresholding to render it binary, calculating shape factors, and assessing pleomorphism using statistical parameters, thereby providing an objective measurement to inform diagnosis and treatment.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If manual histological assessment is used, then diagnostic flexibility and contextual understanding are improved, but measurement objectivity and consistency deteriorate
Solution Approach 1:
The patent replaces manual visual assessment by pathologists with an automated image processing system. The system uses computational algorithms to automatically identify cell nuclei, calculate shape factors, and assess pleomorphism, eliminating human subjectivity from the measurement process while maintaining diagnostic accuracy.
Solution Approach 2:
The patent transforms qualitative histological assessment into quantitative parameters. It calculates shape factors (perimeter, area, circularity) and statistical parameters (mean, median, standard deviation) of nuclear morphology, converting subjective visual evaluation into objective numerical data that can be consistently measured and compared.
2Measurement precision
If automated image processing is applied, then measurement objectivity is improved, but system complexity and computational requirements deteriorate
Solution Approach 1:
The patent divides the complex image processing task into distinct sequential steps: (1) loading and preprocessing images, (2) identifying cell nuclei regions, (3) calculating shape factors, (4) computing statistical parameters, and (5) assessing pleomorphism. This segmentation makes the complex system more manageable and easier to implement.
Solution Approach 2:
The patent introduces intermediate calculations and processing steps that bridge the raw image data and the final pleomorphism assessment. Shape factors serve as intermediaries that translate complex nuclear morphology into quantifiable parameters, simplifying the overall assessment process while maintaining objectivity.
3Ease of operation
If manual assessment is used, then contextual interpretation is improved, but assessment time and productivity deteriorate
Solution Approach 1:
The system performs self-service by automatically completing the entire pleomorphism assessment process without requiring pathologist intervention for each individual measurement. The automated algorithms independently identify nuclei, calculate metrics, and generate assessments, dramatically increasing throughput while pathologists retain oversight for contextual interpretation.
4Reliability
If quantitative shape factor analysis is implemented, then measurement consistency is improved, but computational processing requirements deteriorate
Solution Approach 1:
The patent applies partial action by focusing computational resources on the most critical aspects of nuclear morphology assessment. It calculates shape factors and statistical parameters only for regions identified as containing cell nuclei, rather than processing the entire image dataset, thereby reducing computational burden while maintaining measurement consistency.
Data Source
AI summary
A method of histological assessment of nuclear pleomorphism to identify potential cell nuclei divides image data into overlapping sub-images. It uses principal component analysis to derive monochromatic image data, followed by Otsu thresholding to produce a binary image. It removes image regions at sub-image boundaries, unsuitably small image regions and holes in relatively large image regions. It then reassembles the resulting sub-images into a single image. Perimeters (P) and areas (A) of image regions which are potential cell nuclei are determined and used in calculating nuclear shape factors P2/A. Nuclear pleomorphism is assessed as relatively low, moderate or high according to whether predetermined shape factor thresholds indicate a mean cell nucleus shape factor for an image is relatively low, moderate or high.